Title : Tolfenamic acid downregulates β-catenin in colon cancer.

Pub. Date : 2016 Jun

PMID : 27089389






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tolfenamic acid downregulates beta-catenin in colon cancer. tolfenamic acid catenin beta 1 Homo sapiens
2 The current study investigates the role of tolfenamic acid on beta-catenin expression in colon cancer. tolfenamic acid catenin beta 1 Homo sapiens
3 Treatment with tolfenamic acid led to inhibition of cell growth and down-regulation of beta-catenin expression in a dose- and time-dependent manner in human colon cancer cell lines. tolfenamic acid catenin beta 1 Homo sapiens
4 Reduction of beta-catenin upon tolfenamic acid treatment was associated with ubiquitin-mediated proteasomal degradation, without affecting mRNA level and promoter activity of beta-catenin. tolfenamic acid catenin beta 1 Homo sapiens
5 In addition, treatment with tolfenamic acid downregulated Smad2 and Smad3 expression, while overexpression of Smad2, but not Smad3, blocked tolfenamic acid-induced suppression of beta-catenin expression. tolfenamic acid catenin beta 1 Homo sapiens
6 Tolfenamic acid also decreased expression of beta-catenin target genes, including vascular endothelial growth factor (VEGF). tolfenamic acid catenin beta 1 Homo sapiens
7 In conclusion, our findings suggest that tolfenamic acid inhibits growth of colon cancer cells through downregulation of Smad2 and, subsequently, facilitating ubiquitin-proteasome-mediated beta-catenin degradation in colon cancer. tolfenamic acid catenin beta 1 Homo sapiens